US Patent 7199124 JNK inhibitor
Patent 7199124 was granted and assigned to Takeda Pharmaceutical Company on April, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Hiroyuki Kimura0
Kenichi Naruo0
Seiji Miwatashi0
Shigenori Ohkawa0
Tomohiro Kawamoto0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+236 characters)
Article
Patent abstract
The present invention relates to a c-Jun N-terminal kinase inhibitor containing an azole compound (I) substituted by a nitrogen-containing aromatic group having substituent(s)(except a compound represented by the formula:
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07199124 JNK inhibitor US Patent 7199124 JNK inhibitor
Infobox
Patent Number
07199124
Patent Number
7199124
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07199124 JNK inhibitor
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07199124
Date of patent
April 3, 2007
Patent application number
10470751
Date Filed
February 1, 2002
Patent primary examiner
Find more entities like US Patent 7199124 JNK inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.